Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01335230 · ClinicalTrials.gov registry record
The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients
A clinical trial, sponsored by University of Cincinnati.
- Completed
- Registry status
- 40
- Enrollment target
NCT01335230 is a clinical trial that has completed, run by University of Cincinnati. The registered enrollment target is 40 participants.
The verdict
NCT01335230 has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The purpose of this research study is to explore what role immune cells within the gut (the sigmoid colon) have locally and on the immune system of patients infected with HCV, HIV or HCV/ HIV co-infection.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2011-04 |
| Est. Completion | 2013-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01335230
The ClinicalTrials.gov registry entry for NCT01335230 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01335230 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01335230 about?
NCT01335230 is a clinical study titled "The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients". The purpose of this research study is to explore what role immune cells within the gut (the sigmoid colon) have locally and on the immune system of patients infected with HCV, HIV or HCV/ HIV co-infection.
What is the current status of trial NCT01335230?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2011-04. Estimated completion is 2013-01.
Who is sponsoring clinical trial NCT01335230?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.